ATE240727T1 - Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen - Google Patents

Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen

Info

Publication number
ATE240727T1
ATE240727T1 AT94912176T AT94912176T ATE240727T1 AT E240727 T1 ATE240727 T1 AT E240727T1 AT 94912176 T AT94912176 T AT 94912176T AT 94912176 T AT94912176 T AT 94912176T AT E240727 T1 ATE240727 T1 AT E240727T1
Authority
AT
Austria
Prior art keywords
lesions
medication
producing
composition containing
topical treatment
Prior art date
Application number
AT94912176T
Other languages
English (en)
Inventor
Bruce A Jack
B Thomas White
Original Assignee
Professional Pharmaceutical In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Pharmaceutical In filed Critical Professional Pharmaceutical In
Application granted granted Critical
Publication of ATE240727T1 publication Critical patent/ATE240727T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT94912176T 1994-03-02 1994-03-02 Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen ATE240727T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/002282 WO1995023601A1 (en) 1994-03-02 1994-03-02 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient

Publications (1)

Publication Number Publication Date
ATE240727T1 true ATE240727T1 (de) 2003-06-15

Family

ID=22242315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912176T ATE240727T1 (de) 1994-03-02 1994-03-02 Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen

Country Status (9)

Country Link
EP (1) EP0706394B1 (de)
JP (1) JP3552168B2 (de)
AT (1) ATE240727T1 (de)
CA (1) CA2160779C (de)
DE (1) DE69432703T2 (de)
DK (1) DK0706394T3 (de)
ES (1) ES2199961T3 (de)
PT (1) PT706394E (de)
WO (1) WO1995023601A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270781B1 (en) 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
ES2225156T3 (es) * 1999-06-03 2005-03-16 Maxim Pharmaceuticals, Inc. Composiciones oftalmicas que contienen histamina y usos de las mismas.
JP2006512279A (ja) * 2002-03-29 2006-04-13 マキシム ファーマシューティカルス，インコーポレイテッド 眼内損傷を治療および予防するためのｒｏｍ生成および放出阻害剤の使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3898325A (en) * 1973-09-19 1975-08-05 American Lipids Corp Method and preparations for relieving pain and producing analgesia
US4228176A (en) * 1979-04-09 1980-10-14 Nelson Research & Development Company Thromboxane inhibition with burimamide
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4618490A (en) * 1980-06-06 1986-10-21 Marco Peter T De Method of treatment of animal and human tissues damaged by burns and frank visible gangrene
US4966892A (en) * 1982-05-07 1990-10-30 Carrington Laboratories, Inc. Processes for preparation of aloe products products produced thereby and compositions thereof
US4705685A (en) * 1982-05-17 1987-11-10 Mcmichael John Methods and materials for treatment of disease states involving immunological factors
US5176912A (en) * 1991-01-29 1993-01-05 Orestes Cabezas Method of treating psoriasis

Also Published As

Publication number Publication date
DE69432703D1 (de) 2003-06-26
EP0706394A4 (de) 2000-06-28
PT706394E (pt) 2003-10-31
EP0706394B1 (de) 2003-05-21
ES2199961T3 (es) 2004-03-01
JP3552168B2 (ja) 2004-08-11
EP0706394A1 (de) 1996-04-17
WO1995023601A1 (en) 1995-09-08
DK0706394T3 (da) 2003-09-22
CA2160779A1 (en) 1995-09-08
DE69432703T2 (de) 2004-03-25
JPH08509994A (ja) 1996-10-22
CA2160779C (en) 2008-08-26

Similar Documents

Publication Publication Date Title
ATE177629T1 (de) Verwendung von 2-hydroxycarbonsäure oder deren derivaten enthaltende zusammensetzung zur linderung von wechseln nagelveränderungen
EP0068552A3 (de) Topisches mikrobizides Präparat
DE69710712T2 (de) Umkehrbare inhibitoren von tyrosin kinasen
DE59803845D1 (de) Sulfinsäurederivate und deren herstellung und verwendung
NO991731L (no) Lokalanestetika for utvortes bruk
ATE217184T1 (de) Verwendung einer ein polymersystem enthaltenden zubereitung
ATE8203T1 (de) Antineoplastische mittel auf basis von nicht oder nur geringfuegig irritierenden und/oder promovierenden diterpenalkoholen und derivaten davon und deren herstellung.
CY1106089T1 (el) Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα
TR199900186T2 (xx) H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler
ATE240727T1 (de) Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen
DE69431162T2 (de) Fenbendazolformulierungen
DE69301877T2 (de) Kosmetische oder dermatologische zusammensetzung in form einer öl-in-wasser dispersion, die verbundfilme bilden kann
ES2137196T3 (es) Formulacion antiseborreica.
FR2358399A1 (fr) 5-m-tolyloxy-uracile, agent anti-ulceres
EP0241889A3 (de) Verwendung von TNF zur Herstellung von Arzneimitteln
FI920425A0 (fi) Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.
ES8701161A1 (es) Un procedimiento para preparar derivados de piridiloxi
GB1242863A (en) 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
JPS5723630A (en) S-(beta-hydroxy-gamma-trimethylammoniopropyl) keratin
Delaney et al. Functional group and substituent effects, both steric and electronic, upon the ultraviolet absorption spectra of some N-alkyl-and N, N-dialkyl-derivatives of some cinnamamides and benzalcyanoacetamides
TH11445EX (th) สารประกอบอินดิโนอินโดล
SE7906941L (sv) Fosfatsalter av 1 - och d,1-glaucin
KR830005113A (ko) 프로테아제 억제물질(Protease Inhibitors)
SE7710661L (sv) Forfarande for framstellning av kromon-2-karboxylsyror
IT1120097B (it) Metodo per la fabbricazione di pannelli da impiegare nelle costruzioni edili quali solai o pareti sia interne che esterne,e pannelli costruiti secondo il metodo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0706394

Country of ref document: EP

REN Ceased due to non-payment of the annual fee